[Hiring] Head of Specialty Therapeutics @LifeStance Health

Role Description

The role will be a clinical authority on neuromodulation and emerging pharmacotherapies (including esketamine, ketamine, and psychedelic-assisted therapies) while overseeing safe, evidence-based program development with the goal of positioning LifeStance as a national leader in interventional psychiatry. This role is responsible for advancing specialty and interventional psychiatric therapeutics by developing protocols, training, quality standards, and outcome measures to support patients.

• Success looks like safe, evidence-based, responsibly scaled specialty therapeutic programs that improve outcomes and align with enterprise clinical and operational priorities.
• This role is part of a team who will be assisting with implementing and guiding the directives of the CMO team.
• We are seeking a highly collaborative, mission-driven professional with strong emotional intelligence, sound judgment, and exceptional executive functioning.
• The ideal candidate is a mature and efficient team player who communicates thoughtfully, remains solutions-oriented under pressure, and consistently puts shared goals above personal agenda.
• This person should be energized by the opportunity to help shape the future of mental healthcare and thrive in a high-accountability environment built on trust, focus, and mutual respect.
• Every member of the LifeStance team is expected to support each other and the mission, which may mean participating in projects and initiatives and performing functions and responsibilities not specifically outlined in this job description.

Qualifications

• MD or DO with board certification in Psychiatry.
• Active, unrestricted medical license and ability to maintain appropriate licensure requirements.
• 10+ years of psychiatric clinical experience, including experience with specialty, interventional, or advanced psychiatric treatment modalities.
• Demonstrated ability to develop clinical protocols, care pathways, safety standards, training models, or program governance structures.
• Strong understanding of clinical evidence review, patient safety, risk management, regulatory considerations, and standards of care for specialty therapeutics.
• Ability to influence clinical and operational leaders across a complex, matrixed organization.
• Excellent written, verbal, facilitation, and executive communication skills.
• Qualified candidates must be legally authorized to be employed in the United States.
• Demonstrates awareness, inclusivity, sensitivity, humility, and experience in working with individuals from diverse ethnic backgrounds, socioeconomic statuses, sexual orientations, gender identities, and other various aspects of culture.

Requirements

• Design and implement an enterprise interventional psychiatry strategy encompassing TMS (including rapid protocols), emerging pharmacotherapies, and neuromodulation modalities.
• Lead clinical program development for psychedelic-assisted therapies (including psilocybin, MDMA, and other emerging agents) in alignment with current and future FDA guidance and DEA regulatory requirements.
• Evaluate emerging specialty treatments using current evidence, regulatory requirements, safety considerations, operational feasibility, and patient need.
• Monitor and synthesize emerging literature in interventional psychiatry to inform strategy and competitive positioning.
• Develop clinical protocols, eligibility criteria, care pathways, quality standards, and safety monitoring expectations for specialty therapeutic programs.
• Oversee implementation, performance monitoring, and continuous improvement of specialty therapeutic services across applicable markets and care settings.
• Oversee training and credentialing standards for clinicians delivering interventional therapies, including structured psychotherapy integration as required by emerging FDA guidance.
• Partner with Medical Leadership, Clinical Operations, Quality, Research, and Finance to ensure specialty programs are clinically sound, operationally feasible, and responsibly governed.
• Partner with legal, compliance, and operations to navigate DEA Schedule I licensing (if necessary), REMS program requirements, and state-level regulatory variation.
• Collaborate with the Director of Emerging and Digital Therapeutics on data collection and outcomes measurement frameworks for interventional programs.
• Monitor outcomes, adverse events, utilization trends, patient experience, and effectiveness measures to guide program improvement and scale decisions.
• Build relationships with academic institutions, research organizations, specialty therapy centers, and external experts to inform clinical strategy and evidence generation.

Benefits

• Medical, dental, vision, AD&D, short and long-term disability, and life insurance.
• 401k retirement savings with employer match.
• Paid parental leave.
• Paid time off.
• Holiday pay.
• Employee Assistance Program.

Compensation

$252,000 - $315,000/annually in addition to a competitive bonus plan and equity potential. LifeStance provides the compensation range and benefits that it in good faith believes it might pay and/or offer for this position. LifeStance reserves the right to ultimately pay more or less than the posted range and offer additional benefits and other compensation, depending on circumstances not related to an applicant’s sex or other status protected by local, state, or federal law.